BIOLOGY OF CANCER:
MICROENVIRONMENT, METASTASIS & THERAPEUTICS
May 12 - 16, 2015
Abstract Deadline: March 9, 2015

Organizers:
Senthil Muthuswamy, Ontario Cancer Institute, Canada    Kornelia Polyak, Dana Farber Cancer Institute     David Tuveson, Cold Spring Harbor Laboratory

You are cordially invited to participate in the third meeting on Biology of Cancer: Microenvironment, Metastasis & Therapeutics to be held at Cold Spring Harbor Laboratory, New York. The meeting will begin on Tuesday, May 12, 2015, and will conclude with lunch on Saturday, May 16. The specific goal of this conference is to nucleate scientists who are investigating these diverse aspects of cancer biology and facilitate discussions aimed at finding ways to combine these fields to develop novel therapeutic strategies to control cancer. The meeting will alternate annually with the CSHL meeting on Mechanisms & Models of Cancer.

The format of the meeting will include morning and evening sessions consisting of eight or nine 15-minute talks per session, selected from the abstracts, principally on unpublished work. In addition, there will be two poster sessions, held in the afternoons. The organizers will decide the suitability of each abstract for oral or poster presentation, but please specify if you prefer a poster. 

Topics Include:
Diagnostic Imaging and Drug Delivery
Cancer Immunology
 Translational Trial/Personalized Cancer Therapy
Cancer as a Systemic Disease
Tumor Microenvironment & Metastasis
Metabolism
Signaling Networks and Therapeutics

Keynote Speaker:
Mina Bissell, Lawrence Berkeley National Laboratory

Confirmed Invited Speakers:
James Bradner, Dana-Farber Cancer Institute, Harvard Medical School
Timothy Chan, Memorial Sloan Kettering Cancer Center
Hans Clevers, Hubrecht Institute, Holland
Luis Diaz, Johns Hopkins University School of Medicine
Mikala Egeblad, Cold Spring Harbor Laboratory
Jeffrey Engelman, Massachusetts General Hospital
Johanna Joyce, Memorial Sloan-Kettering Cancer Center
David Lyden, Weill Cornell Medical College
Tak Mak, University of Toronto, Canada
Elaine Mardis, Washington University School of Medicine
David Piwnica-Worms, UT MD Anderson Cancer Center
David Solit, Memorial Sloan-Kettering Cancer Center
Alana Welm, Oklahoma Medical Research Foundation

Panel Session:
Will the ineffectiveness of oncology trials be rescued by "personalized medicine?"

Abstracts should contain only new and unpublished material and must be submitted electronically by the abstract deadline. Selection of material for oral and poster presentation will be made by the organizers and individual session chairs. Status (talk/poster) of abstracts will be posted on our web site as soon as decisions have been made by the organizers.

 We are eager to have as many young people as possible attend since they are likely to benefit most from this meeting. We have applied for funds from government and industry to partially support graduate students and postdocs. Apply in writing to Val Pakaluk stating need for financial support - preference is given to those submitting abstracts.

We look forward to seeing you at Cold Spring Harbor in May.